#348: NIPT Beyond the Basics: Screening for Single-Gene Conditions

<p>Prenatal screening has transformed over the past decade, with Non-Invasive Prenatal Testing, or NIPT, becoming a go-to tool for early risk assessment. But even as adoption increases globally, we’re still facing real gaps, from limited condition coverage to a lack of support in interpreting results.</p> <p> </p> <p>On this episode, I’m joined by <a href='https://www.linkedin.com/in/fredushakov/'>Dr. Fred Ushakov</a>, a renowned fetal medicine expert based in London. We are going to explore how NIPT is evolving and how a next-generation screening tool like Fulgent’s KNOVA is pushing the boundaries of early detection. </p> <p> </p> <p>We’ll also dive into how structural scans and single-gene conditions factor into smarter screening strategies, and what patients and providers alike need to know when choosing the right test. </p> <p> </p> <p>What We Cover in This Episode:</p> <ul> <li style="font-weight:400;">The current state of NIPT access and adoption in the UK (public vs. private hea...